Why is Krebs Biochem falling/rising?

As of 09-Jul, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 82.26, reflecting a decrease of Rs 2.74 or 3.22%. The stock has underperformed its sector by 3.42% today and has been on a consecutive downward trend for the last two days, with a total decline of 4.35% during this period. Additionally, the stock has shown significant underperformance over various time frames, including a 21.06% drop over the past month and a 19.98% decline over the last three years. The company has reported negative results for the last two consecutive quarters, with a negative book value and a high debt-to-equity ratio, indicating weak long-term fundamental strength.
In the broader market context, the stock's performance contrasts sharply with the benchmark, as the Sensex has gained 0.15% over the past week and 1.32% over the past month, while Krebs Biochem has seen a 5.69% decline in the same one-week period. This consistent underperformance against the benchmark highlights the company's struggles, particularly given its negative EBITDA and declining profits, which have fallen by 36.5% over the past year. The falling investor participation, as evidenced by a significant drop in delivery volume, further suggests a lack of confidence among investors, contributing to the stock's downward trajectory.